PO141 SUCCESSFUL USE OF HER2 TARGETED AGENTS IN PATIENTS WITH HEAVILY PRETREATED HER2-NEGATIVE METASTATIC BREAST CANCER PRESENTING WITH ELEVATED SERUM LEVELS OF THE HER2 EXTRACELLULAR DOMAIN AND/OR HER2 OVEREXPRESSING CIRCULATING TUMOR CELLS

Autor: Kurbacher, Christian Martin, Quade, Annegret, Kunstmann, Gerhard, Herz, Susanne, Kurbacher, Jutta Anna, Warm, Matthias R.
Zdroj: In The Breast November 2015 24 Supplement 3:S70-S70
Databáze: ScienceDirect